University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania

University of Pittsburgh Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Pittsburgh Cancer Institute has participated in 187 clinical trials with 2 currently active.

Therapeutic areas: Carcinoma, Squamous Cell of Head and Neck, Non-Small Cell Lung Cancer, Leukemia.

Sponsors: Celgene, University of Colorado, Denver, Sunesis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pittsburgh Cancer Institute?

University of Pittsburgh Cancer Institute has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pittsburgh Cancer Institute conducted?

University of Pittsburgh Cancer Institute has 187 clinical trials on record, with 2 currently active. Their work covers Carcinoma, Squamous Cell of Head and Neck, Non-Small Cell Lung Cancer, Leukemia.

Is University of Pittsburgh Cancer Institute accredited by Crixeo Health?

University of Pittsburgh Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pittsburgh Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.